Grade 3b Follicular Lymphoma — Trials

Grade 3b Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

40 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 23%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04156828	Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma	terminated	Phase 1	12	University of WashingtonOTHER	1	Jun 29, 2023	clinicaltrials
NCT02592876	Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma	terminated	Phase 2	81	Seagen Inc.INDUSTRY	1	May 17, 2019	clinicaltrials